-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Anika Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2010 to 2024.
- Anika Therapeutics, Inc. Costs and Expenses for the quarter ending December 31, 2024 was -$5.25M, a 72.2% increase year-over-year.
- Anika Therapeutics, Inc. Costs and Expenses for the twelve months ending December 31, 2024 was $81.1M, a 0.72% decline year-over-year.
- Anika Therapeutics, Inc. annual Costs and Expenses for 2024 was $81.1M, a 0.72% decline from 2023.
- Anika Therapeutics, Inc. annual Costs and Expenses for 2023 was $81.7M, a 17.5% increase from 2022.
- Anika Therapeutics, Inc. annual Costs and Expenses for 2022 was $69.6M, a 13.4% decline from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)